NCT03658616View on ClinicalTrials.gov

Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.

PHASE3CompletedINTERVENTIONAL

Enrollment

518

Participants

Timeline

Start Date

September 18, 2018

Primary Completion Date

November 2, 2021

Study Completion Date

February 2, 2022

Conditions

Primary Axillary Hyperhidrosis

Interventions

DRUG

WO3970

Application of cream to each axilla

DRUG

Placebo (WO3988)

Application of cream to each axilla

Trial Locations (1)

24148

Dr. Harald Brüning, Kiel

All Listed Sponsors

lead

Dr. August Wolff GmbH & Co. KG Arzneimittel

INDUSTRY

NCT03658616 - Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis. | Biotech Hunter | Biotech Hunter